Toronto-Dominion Bank »

Urogen Pharma shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2023-09-30 $84 6 14.00

More positions owned by Toronto-Dominion Bank

Charles Schwab Corporation (SCHW)
Invesco QQQ Trust Series 1 Etf (QQQ)
Rbc Cad (RY)
Apple (AAPL)
Microsoft Corporation (MSFT)
SPDR S&P 500 ETF Trust Etf (SPY)
iShares Russell 2000 ETF Etf (IWM)
Bank Of Montreal Cadcom (BMO)
Cibc Cad (CM)
Bk Nova Cad (BNS)
Tc Energy Corp (TRP)
Tor Dom Bk Cad (TD)
SPDR Gold Shares Etf (GLD)
NVIDIA Corporation (NVDA)
Canadian Natural Resources (CNQ)

View all positions for Toronto-Dominion Bank

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma